Rachel King - Nov 12, 2024 Form 3 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Director
Signature
/s/ Alan Musso as attorney-in-fact for Rachel King
Stock symbol
FULC
Transactions as of
Nov 12, 2024
Transactions value $
$0
Form type
3
Date filed
11/14/2024, 04:10 PM
Previous filing
Jun 14, 2024

No securities are beneficially owned.

Remarks:

Exhibit Index: 24.1 Power of Attorney